A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

Clinical trial NCT05635747 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05635747
Sponsor: Boston Children's Hospital
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Short Bowel Syndrome Malabsorption

Start date: 2022-09-29
Primary completion: 2026-09-29
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.